Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

158.24 -1.89 (-1.18%)
Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Looking Into Johnson & Johnson's Recent Short Interest
Via Benzinga
3 Dividend Kings Whose Growth Streaks Could Break Before 2030
Investors should be careful with these high-yielding dividend stocks, as they aren't as safe as they may have been even a few years ago. 
Via The Motley Fool
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
Via Investor Brand Network
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END 
Via FinancialNewsMedia
Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?
Kenvue's operations are diverse, boasting many strong brands. Is that enough to make this a solid dividend stock to own? 
Via The Motley Fool
Investor patience tested as pharmaceutical stocks take a tumble
The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector 
Via MarketBeat
Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK
GSK plc (NYSE: GSK) and Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) have  
Via Benzinga
J&J stock down as business unit mulls talc-related bankruptcy
Johnson & Johnson stock fell in the past week as talc-related lawsuits weigh on a subsidiary, which is mulling bankruptcy to mitigate payouts and settlements. 
Via MarketBeat
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Nearly 70% of Warren Buffett's $326 Billion Portfolio Is Invested in These 9 Megacap Stocks
The Oracle of Omaha likes big stocks. 
Via The Motley Fool
Warren Buffett's $690 Million Secret Portfolio Is Buying 3 Historically Cheap Stocks
The Oracle of Omaha's under-the-radar investment portfolio is buying shares of three industry-leading businesses. 
Via The Motley Fool
Meta's Plans, Cyberattacks, and the EV Race
And we've got a look at two stocks worth watching: Chevron and Burford Capital. 
Via The Motley Fool
Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime
These elite companies make exceptional foundational investments for any portfolio. 
Via The Motley Fool
Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now
A few hundred dollars invested today could go a long way over time. 
Via The Motley Fool
Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs
Ozempic, Novo Nordisk’s (NYSE: NVO) diabetes drug, is now popular for weight loss. The rise of the drug could become a major headwind for other companies that provide weight-loss services such... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie
The FDA approved Eli Lilly And Co's  
Via Benzinga
Exposures Product Safety
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
The happy talk in Sanofi's press release didn't help with analysts, who have been disappointed in the company and SNY stock all year. 
Via InvestorPlace
3 Stocks to Buy (and Never Ever Sell)
You will not regret investing in these three forever stocks that will continue to generate passive income for you. 
Via InvestorPlace
2 Magnificent Dividend Stocks That Could Deliver a Lifetime of Passive Income
These two healthcare stocks are proven passive income vehicles. 
Via The Motley Fool
3 Pharma Stocks That Are Screaming Buys in October
Each company delivers an above-average dividend and revenue growth. 
Via The Motley Fool
Dow Jones Bear Market: 3 Cheap Stocks to Buy Now
The market sell-off has given investors the chance to pick up these leading blue chips at favorable entry points. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Are These 3 Dividend Aristocrats Undervalued Hidden Gems?
Dividend aristocrats Caterpillar, NextEra, and Clorox have shown resilience in challenging times. These may offer opportunities as they are trading off highs. 
Via MarketBeat
Exposures COVID-19
The 7 Best Forever Stocks to Buy for October 2023
These forever stocks have held up incredibly well despite the economic troubles offering healthy upside compared to its peers. 
Via InvestorPlace
2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?
Attractive valuation metrics don't always tell the whole story. 
Via The Motley Fool
3 High-Yielding Dividend Stocks Near Their 52-Week Lows
Due to their declining share prices, Johnson & Johnson, Bank of America, and Target all yield more than 3% right now. 
Via The Motley Fool
The Best Stocks to Invest $5,000 In Right Now
Today, the following three healthcare players look like fantastic bargains. 
Via The Motley Fool
2 Historically Cheap Dow Dividend Kings That Are Ripe for the Picking
These inexpensive Dow components have achieved royalty status among income stocks -- more than 60 consecutive years of dividend increases. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
From Johnson & Johnson
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The Value Deepens for Medtech Stocks: Reversal Imminent
MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows. 
Via MarketBeat
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.